Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Diabetes
|
January 1, 1997
Counterregulation in peripheral tissues: effect of systemic hypoglycemia on levels of substrates and catecholamines in human skeletal muscle and adipose tissue
D G Maggs, R Jacob, F Rife, et al.
Diabetes, Obesity & Metabolism
|
June 1, 2011
Cardiovascular outcomes associated with a new once-weekly GLP-1 receptor agonist vs. traditional therapies for type 2 diabetes: a simulation analysis
B R Peskin, A V Shcheprov, K S Boye, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association
|
May 14, 2005
Adjunctive therapy with pramlintide lowers HbA1c without concomitant weight gain and increased risk of severe hypoglycemia in patients with type 1 diabetes approaching glycemic targets
R Ratner, F Whitehouse, M S Fineman, et al.
Metabolism: Clinical and Experimental
|
April 30, 2002
The human amylin analog, pramlintide, corrects postprandial hyperglucagonemia in patients with type 1 diabetes
M S Fineman, J E Koda, L Z Shen, et al.
The American Journal of Physiology
|
May 12, 1998
Effect of insulin on glycerol production in obese adolescents
C Robinson, W V Tamborlane, D G Maggs, et al.
The Journal of Clinical Investigation
|
July 1, 1995
Interstitial fluid concentrations of glycerol, glucose, and amino acids in human quadricep muscle and adipose tissue. Evidence for significant lipolysis in skeletal muscle
D G Maggs, R Jacob, F Rife, et al.
The New England Journal of Medicine
|
March 27, 1998
Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus
S E Inzucchi, D G Maggs, G R Spollett, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
October 23, 2004
Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial
R E Ratner, R Dickey, M Fineman, et al.
Diabetes, Obesity & Metabolism
|
July 30, 2005
The effect of pramlintide on hormonal, metabolic or symptomatic responses to insulin-induced hypoglycaemia in patients with type 1 diabetes
S A Amiel, S R Heller, I A Macdonald, et al.
Annals of Internal Medicine
|
February 7, 1998
Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial
D G Maggs, T A Buchanan, C F Burant, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Diabetes
|
January 1, 1997
Counterregulation in peripheral tissues: effect of systemic hypoglycemia on levels of substrates and catecholamines in human skeletal muscle and adipose tissue
D G Maggs, R Jacob, F Rife, et al.
Diabetes, Obesity & Metabolism
|
June 1, 2011
Cardiovascular outcomes associated with a new once-weekly GLP-1 receptor agonist vs. traditional therapies for type 2 diabetes: a simulation analysis
B R Peskin, A V Shcheprov, K S Boye, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association
|
May 14, 2005
Adjunctive therapy with pramlintide lowers HbA1c without concomitant weight gain and increased risk of severe hypoglycemia in patients with type 1 diabetes approaching glycemic targets
R Ratner, F Whitehouse, M S Fineman, et al.
Metabolism: Clinical and Experimental
|
April 30, 2002
The human amylin analog, pramlintide, corrects postprandial hyperglucagonemia in patients with type 1 diabetes
M S Fineman, J E Koda, L Z Shen, et al.
The American Journal of Physiology
|
May 12, 1998
Effect of insulin on glycerol production in obese adolescents
C Robinson, W V Tamborlane, D G Maggs, et al.
The Journal of Clinical Investigation
|
July 1, 1995
Interstitial fluid concentrations of glycerol, glucose, and amino acids in human quadricep muscle and adipose tissue. Evidence for significant lipolysis in skeletal muscle
D G Maggs, R Jacob, F Rife, et al.
The New England Journal of Medicine
|
March 27, 1998
Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus
S E Inzucchi, D G Maggs, G R Spollett, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
October 23, 2004
Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial
R E Ratner, R Dickey, M Fineman, et al.
Diabetes, Obesity & Metabolism
|
July 30, 2005
The effect of pramlintide on hormonal, metabolic or symptomatic responses to insulin-induced hypoglycaemia in patients with type 1 diabetes
S A Amiel, S R Heller, I A Macdonald, et al.
Annals of Internal Medicine
|
February 7, 1998
Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial
D G Maggs, T A Buchanan, C F Burant, et al.
Page
of 2